Oxford Nanopore Technologies (ONT) Share Price, News & Analysis

Company Overview

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company operates in Life Science Research Tools and Covid Testing segments. It offers MinION, a portable device for DNA and RNA; GridION, a flexible and self-contained benchtop nanopore sequencer to run and analyse up to five MinION or Flongle flow cells; MinION Mk 1C, a nano pore-based sequencer with analysis software and connectivity for self-contained and portable sequencing; Flongle, an adapter for MinION or GridION that enables DNA sequencing or cDNA sequencing on smaller and single-use flow cells; and PromethION 2 Solo, a sequencer for two PromethION flow cells. The company also provides PromethION 2, a self-contained benchtop nanopore sequencer; PromethION 24, which provides single or multiple users with access to terabases of sequencing data; PromethION 48, a sequencing device with high-output flow cells; VolTRAX, an automated library prep for nanopore analyses; and Q-Line, a sequencing for applied applications, as well as products for SAR-Cov-2 testing. Its platform enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.

Key Stats

• Today's Range: 130.80 to 142.10
• 50-Day Range: 131.40 to 164.30
• 52-Week Range: 85 to 212.59
• Volume: 4.06 million shs
• Average Volume: 1.93 million shs
• Market Capitalization: £1.32 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: GBX 235.50
• Consensus Rating: Buy

Oxford Nanopore Technologies Stock Analysis - MarketRank™

Oxford Nanopore Technologies scored higher than 55% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Oxford Nanopore Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Oxford Nanopore Technologies has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Oxford Nanopore Technologies is -699.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Oxford Nanopore Technologies is -699.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Oxford Nanopore Technologies has a P/B Ratio of 2.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for ONT.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Oxford Nanopore Technologies does not currently pay a dividend.

Dividend Growth

Oxford Nanopore Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for ONT.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 1.14

News Sentiment

Oxford Nanopore Technologies has a news sentiment score of 1.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Oxford Nanopore Technologies this week, compared to 1 article on an average week.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Oxford Nanopore Technologies insiders have sold 631,086.36% more of their company's stock than they have bought. Specifically, they have bought £448.50 in company stock and sold £2,830,870.82 in company stock.

Percentage Held by Insiders

32.62% of the stock of Oxford Nanopore Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 38.37% of the stock of Oxford Nanopore Technologies is held by institutions.

ONT Stock Analysis - Frequently Asked Questions

How have ONT shares performed this year?

Oxford Nanopore Technologies' stock was trading at GBX 208.20 at the beginning of the year. Since then, ONT stock has decreased by 32.8% and is now trading at GBX 139.89.
View the best growth stocks for 2024 here.

How do I buy shares of Oxford Nanopore Technologies?

Shares of ONT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Oxford Nanopore Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Oxford Nanopore Technologies investors own include Vodafone Group Public (VOD), easyJet (EZJ), Oxford Nanopore Technologies (ONTTF), BP (BP), Ecora Resources (ECOR), Glencore (GLEN) and HSBC (HSBA).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: LON:ONT
• CUSIP: N/A
• CIK: N/A
• Web: nanoporetech.com
• Phone: 44 84 5034 7900
• Fax: N/A
• Employees: 1,281
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: GBX 235.50
• High Stock Price Target: GBX 282
• Low Stock Price Target: GBX 190
• Potential Upside/Downside: +68.3%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 5 Analysts

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.20)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-159,060,000.00
• Net Margins: -94.82%
• Pretax Margin: N/A
• Return on Equity: -26.08%
• Return on Assets: -14.42%

Debt

• Debt-to-Equity Ratio: 8.07
• Current Ratio: 4.45
• Quick Ratio: 6.01

Sales & Book Value

• Annual Sales: £167.75 million
• Price / Sales: 7.85
• Cash Flow: GBX 34.62 per share
• Price / Cash Flow: 4.04
• Book Value: GBX 66 per share
• Price / Book: 2.12

Miscellaneous

• Outstanding Shares: 941,450,000
• Free Float: N/A
• Market Cap: £1.32 billion
• Optionable: Not Optionable
• Beta: 0.80